Lvw Advisors, LLC Novo Nordisk A S Transaction History

Lvw Advisors, LLC

$771 Million
Q3 2024

A detailed history of Lvw Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Lvw Advisors, LLC holds 15,244 shares of NVO stock, worth $1.6 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

15,244

Previous 16,641 8.39%

Holding current value

$1.6 Million

Previous $2.38 Million 23.58%

% of portfolio

0.24%

Previous 0.35%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$119.07 - $145.42 $166,340 - $203,151	-1,397 Reduced 8.39%	15,244 $1.82 Million
Q2 2024 Jul 15, 2024	BUY	$122.71 - $146.91 $27,364 - $32,760	223 Added 1.36%	16,641 $2.38 Million
Q1 2024 Apr 17, 2024	SELL	$102.11 - $135.92 $63,716 - $84,814	-624 Reduced 3.66%	16,418 $2.11 Million
Q4 2023 Jan 12, 2024	SELL	$87.78 - $105.45 $62,323 - $74,869	-710 Reduced 4.0%	17,042 $1.76 Million
Q3 2023 Oct 10, 2023	BUY	$90.94 - $199.54 $573,558 - $1.26 Million	6,307 Added 55.11%	17,752 $1.61 Million
Q2 2023 Jul 14, 2023	SELL	$155.98 - $172.65 $54,125 - $59,909	-347 Reduced 2.94%	11,445 $1.85 Million
Q1 2023 May 02, 2023	BUY	$132.34 - $159.14 $16,674 - $20,051	126 Added 1.08%	11,792 $1.88 Million
Q4 2022 Jan 18, 2023	SELL	$102.55 - $135.33 $197,408 - $260,510	-1,925 Reduced 14.16%	11,666 $0
Q3 2022 Oct 13, 2022	SELL	$95.28 - $116.93 $58,787 - $72,145	-617 Reduced 4.34%	13,591 $1.35 Million
Q2 2022 Jul 22, 2022	BUY	$103.24 - $121.81 $206,892 - $244,107	2,004 Added 16.42%	14,208 $1.58 Million
Q1 2022 May 02, 2022	SELL	$93.1 - $112.54 $424,163 - $512,732	-4,556 Reduced 27.18%	12,204 $1.36 Million
Q4 2021 Jan 26, 2022	SELL	$95.88 - $117.08 $56,281 - $68,725	-587 Reduced 3.38%	16,760 $1.88 Million
Q3 2021 Nov 02, 2021	SELL	$84.42 - $106.62 $21,273 - $26,868	-252 Reduced 1.43%	17,347 $1.67 Million
Q2 2021 Jul 15, 2021	SELL	$67.66 - $84.76 $2,909 - $3,644	-43 Reduced 0.24%	17,599 $1.47 Million
Q1 2021 Apr 19, 2021	BUY	$67.06 - $75.82 $157,188 - $177,722	2,344 Added 15.32%	17,642 $1.19 Million
Q4 2020 Feb 04, 2021	SELL	$63.89 - $73.8 $10,286 - $11,881	-161 Reduced 1.04%	15,298 $1.07 Million
Q3 2020 Oct 29, 2020	SELL	$63.69 - $70.22 $115,915 - $127,800	-1,820 Reduced 10.53%	15,459 $1.07 Million
Q2 2020 Aug 11, 2020	BUY	$58.54 - $67.94 $44,373 - $51,498	758 Added 4.59%	17,279 $1.13 Million
Q1 2020 Apr 23, 2020	BUY	$49.46 - $64.78 $268,023 - $351,042	5,419 Added 48.81%	16,521 $995,000
Q4 2019 Feb 10, 2020	BUY	$49.86 - $58.26 $211,356 - $246,964	4,239 Added 61.77%	11,102 $643,000
Q3 2019 Oct 22, 2019	BUY	$47.54 - $53.43 $326,267 - $366,690	6,863 New	6,863 $355,000

Others Institutions Holding NVO

# of Institutions

1,954

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $237B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvw Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lvw Advisors, LLC with notifications on news.

Account